INO SCHEDULE 13G: SEC filing
ADAR1 Capital Management, LLC and Daniel Schneeberger
Filed with the SEC on · accession 0001104659-26-128721
INO filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Schedule 13G reporting beneficial ownership of 6,429,624 shares (7.4%) of Inovio Pharmaceuticals common stock, including 4,285,714 shares underlying Tranche A and B warrants. The stock moved -2.1% by the first close after the filing.
Summary of the filing
ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Schedule 13G reporting beneficial ownership of 6,429,624 shares (7.4%) of Inovio Pharmaceuticals common stock, including 4,285,714 shares underlying Tranche A and B warrants. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
How INO stock reacted
Close before
$1.43
Nov 13, 2026
First close after
-2.10%
$1.40
5 trading days
—
Since filing
+13.99%
$1.63
✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INO?
Click hereFrequently asked questions
What did INO file with the SEC on Nov 16, 2026?
INO filed a SCHEDULE 13G (SEC filing). ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Schedule 13G reporting beneficial ownership of 6,429,624 shares (7.4%) of Inovio Pharmaceuticals common stock, including 4,285,714 shares underlying Tranche A and B warrants. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did INO stock react to this filing?
INO closed at $1.43 before the filing and $1.40 on Nov 16, 2026 (-2.10%).
Other INO SEC filings
- 8-K · Board changeNov 17, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- 8-K · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 10, 2026
- 8-K · Secondary offeringNov 9, 2026
- 424B5 · Secondary offeringNov 6, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days